|
Takeshi Nagasaka
Department Kawasaki Medical School , Position Professor |
|
| Language | English |
| Title | Analysis of UGT1A's polymorphisms and RAS: RAF mutations based on phase II study of biweekly XELIRI plus bevacizumab as a second-line therapy in patients with metastatic colorectal cancer. |
| Conference | ASCO GI 2019 |
| Conference Type | International society and overseas society |
| Presentation Type | Poster notice |
| Lecture Type | General |
| Publisher and common publisher | ◎Hiroaki Tanioka, Nobuaki Suzuki, Shoichi Hazama, Takeshi Nagasaka, Yasuo Iwamoto, Yuji Negoro, Yuki Nakagami, Ryouichi Tsunedomi, Hiroaki Nagano, Masazumi Okajima |
| Date | 2019/01/19 |
| Venue (city and name of the country) |
San Francisco, CA, USA |